A new breast cancer jab will cut the amount of time patients have to spend in hospital from two-and-a-half hours to just five minutes.
The treatment, called Phesgo, is being rolled out across England by the NHS and will be offered to breast cancer patients undergoing chemotherapy.
It will be available to people with HER2-positive breast cancer, which accounts for 15% of all such cancers.
NHS England said the jab “significantly cuts” the Covid-19 infection risk for cancer patients by reducing the amount of time they have to spend in hospital.
Baroness Delyth Morgan, chief executive of the charity Breast Cancer Now, said the approval of Phesgo on the NHS was “fantastic news” for thousands of women who will benefit from a “quicker and kinder” treatment method.
She said: “Reducing the time patients need to spend in hospital, this more efficient treatment method also promises to free up precious time for healthcare professionals when the NHS is already under unprecedented strain due to Covid-19.”
More than 3,600 new patients each year will benefit from…
